Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 May;41(5):950–955. doi: 10.1128/aac.41.5.950

Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.

L Licata 1, C E Smith 1, R M Goldschmidt 1, J F Barrett 1, M Frosco 1
PMCID: PMC163831  PMID: 9145850

Abstract

The postantibiotic subminimum inhibitory concentration effect (PA SME) may simulate in vivo drug exposure more accurately than the postantibiotic effect (PAE) since subinhibitory concentrations of drug persist between antibiotic dosings. In this study, we compared the PAEs and PA SMEs of levofloxacin and ciprofloxacin for clinical isolates of fluoroquinolone-susceptible Staphylococcus aureus and Streptococcus pneumoniae. At two times the MIC, PAEs of levofloxacin were an average of 0.6 h longer than the PAEs obtained for ciprofloxacin for methicillin-susceptible and methicillin-resistant S. aureus strains. The PAEs of levofloxacin and ciprofloxacin ranged from 1.8 to 3.1 and 1.1 to 2.4 h, respectively. Continued exposure of the methicillin-resistant strain to 1/16, 1/8, and 1/4 the MIC resulted in PA SMEs of 6.5, 15.3, and >22.3 h, respectively, for levofloxacin and 3.8, 8.0, and 12.3 h, respectively, for ciprofloxacin. For isolates of S. pneumoniae, at two times the MIC of both fluoroquinolones, the average PAEs of levofloxacin and ciprofloxacin were equivalent: 1.3 h for the penicillin-susceptible isolate and 0.6 h for the penicillin-resistant isolate. Continued exposure of the penicillin-susceptible S. pneumoniae strain to 1/16, 1/8, and 1/4 the MIC resulted in average PA SMEs of 1.0, 1.4, and 2.8 h, respectively, for levofloxacin and 1.8, 2.0, and 2.5 h, respectively, for ciprofloxacin. Continued exposure of penicillin-resistant S. pneumoniae to 1/16, 1/8, and 1/4 the MIC of the same fluoroquinolones resulted in average PA SMEs of 0.6, 1.1, and 2.9 h, respectively, for levofloxacin and 0.6, 1.1, and 1.5 h, respectively, for ciprofloxacin. The PA SMEs observed demonstrate the superior activity of levofloxacin against methicillin-susceptible or methicillin-resistant S. aureus. Although PAEs were similar for the penicillin-susceptible and penicillin-resistant S. pneumoniae strains, the PA SME of levofloxacin at one-fourth the MIC was longer for penicillin-resistant S. pneumoniae.

Full Text

The Full Text of this article is available as a PDF (285.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altemeier W. A. Penicillin Therapy with Prolonged Interval Dosage Schedules. Ann Surg. 1948 Oct;128(4):708–713. doi: 10.1097/00000658-194810000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cars O., Odenholt-Tornqvist I. The post-antibiotic sub-MIC effect in vitro and in vivo. J Antimicrob Chemother. 1993 May;31 (Suppl 500):159–166. doi: 10.1093/jac/31.suppl_d.159. [DOI] [PubMed] [Google Scholar]
  3. Fu K. P., Foleno B., Rosenthale M. E. The postantibiotic suppressive effect of L-ofloxacin, an optically active isomer of ofloxacin. Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):375–378. doi: 10.1016/0732-8893(92)90028-r. [DOI] [PubMed] [Google Scholar]
  4. Fu K. P., Lafredo S. C., Foleno B., Isaacson D. M., Barrett J. F., Tobia A. J., Rosenthale M. E. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother. 1992 Apr;36(4):860–866. doi: 10.1128/aac.36.4.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fuursted K. Post-antibiotic effect of ciprofloxacin on Pseudomonas aeruginosa. Eur J Clin Microbiol. 1987 Jun;6(3):271–274. doi: 10.1007/BF02017611. [DOI] [PubMed] [Google Scholar]
  6. Gottfredsson M., Erlendsdóttir H., Gudmundsson A., Gudmundsson S. Different patterns of bacterial DNA synthesis during postantibiotic effect. Antimicrob Agents Chemother. 1995 Jun;39(6):1314–1319. doi: 10.1128/aac.39.6.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Houston A. K., Jones R. N. Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin. Diagn Microbiol Infect Dis. 1994 Jan;18(1):57–59. doi: 10.1016/0732-8893(94)90134-1. [DOI] [PubMed] [Google Scholar]
  8. Howard B. M., Pinney R. J., Smith J. T. Post-antibiotic effects of ofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pyogenes. Chemotherapy. 1993 Jul-Aug;39(4):265–271. doi: 10.1159/000239135. [DOI] [PubMed] [Google Scholar]
  9. Kunin C. M. Dosage schedules of antimicrobial agents: a historical review. Rev Infect Dis. 1981 Jan-Feb;3(1):4–11. doi: 10.1093/clinids/3.1.4. [DOI] [PubMed] [Google Scholar]
  10. Lorian V. Some effects of subinhibitory concentrations of antibiotics on bacteria. Bull N Y Acad Med. 1975 Oct;51(9):1046–1055. [PMC free article] [PubMed] [Google Scholar]
  11. MacKenzie F. M., Gould I. M. The post-antibiotic effect. J Antimicrob Chemother. 1993 Oct;32(4):519–537. doi: 10.1093/jac/32.4.519. [DOI] [PubMed] [Google Scholar]
  12. McGrath B. J., Marchbanks C. R., Gilbert D., Dudley M. N. In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin. Antimicrob Agents Chemother. 1993 Aug;37(8):1723–1725. doi: 10.1128/aac.37.8.1723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Meng X., Nightingale C. H., Sweeney K. R., Quintiliani R. Loss of bactericidal activities of quinolones during the post-antibiotic effect induced by rifampicin. J Antimicrob Chemother. 1994 Apr;33(4):721–728. doi: 10.1093/jac/33.4.721. [DOI] [PubMed] [Google Scholar]
  14. Odenholt-Tornqvist I., Bengtsson S. Postantibiotic effect, and postantibiotic effect of subinhibitory concentrations, of sparfloxacin on gram-negative bacteria. Chemotherapy. 1994 Jan-Feb;40(1):30–36. doi: 10.1159/000239167. [DOI] [PubMed] [Google Scholar]
  15. Odenholt-Tornqvist I., Löwdin E., Cars O. Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro. Antimicrob Agents Chemother. 1991 Sep;35(9):1834–1839. doi: 10.1128/aac.35.9.1834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Odenholt-Tornqvist I., Löwdin E., Cars O. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob Agents Chemother. 1992 Sep;36(9):1852–1858. doi: 10.1128/aac.36.9.1852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Odenholt-Tornqvist I. Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem. J Antimicrob Chemother. 1993 Jun;31(6):881–892. doi: 10.1093/jac/31.6.881. [DOI] [PubMed] [Google Scholar]
  18. Odenholt I., Holm S. E., Cars O. Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro. J Antimicrob Chemother. 1989 Aug;24(2):147–156. doi: 10.1093/jac/24.2.147. [DOI] [PubMed] [Google Scholar]
  19. Oshida T., Onta T., Nakanishi N., Matsushita T., Yamaguchi T. Activity of sub-minimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus. J Antimicrob Chemother. 1990 Jul;26(1):29–38. doi: 10.1093/jac/26.1.29. [DOI] [PubMed] [Google Scholar]
  20. Pastor A., Pemán J., Cantón E. In-vitro postantibiotic effect of sparfloxacin and ciprofloxacin against Pseudomonas aeruginosa and Enterococcus faecalis. J Antimicrob Chemother. 1994 Nov;34(5):679–685. doi: 10.1093/jac/34.5.679. [DOI] [PubMed] [Google Scholar]
  21. Tsui S. Y., Yew W. W., Li M. S., Chan C. Y., Cheng A. F. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum. Antimicrob Agents Chemother. 1993 May;37(5):1001–1003. doi: 10.1128/aac.37.5.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Visalli M. A., Jacobs M. R., Appelbaum P. C. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother. 1996 Feb;40(2):362–366. doi: 10.1128/aac.40.2.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Zhanel G. G., Craig W. A. Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides. Clin Pharmacokinet. 1994 Nov;27(5):377–392. doi: 10.2165/00003088-199427050-00005. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES